← Eichor
Study identifier: NCT06688344 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Efficacy of Focused Extracorporeal Shock Wave Therapy After Anterior Cruciate Ligament Reconstruction

Condition: ACL Reconstruction · Extracorpereal Shock Wave Therapy  ·  Sponsor: Berivan Beril Kılıç

PhaseNA
Planned participants32
Who can joinAll sexes, 18 Years to 45 Years
Healthy volunteersNo

About this study

The aim of this clinical trial is to determine the effectiveness of fESWT in rehabilitation after ACL reconstruction. The main questions it aims to answer are: Is fESWT applied in addition to conventional physiotherapy effective in physiotherapy-related parameters? Researchers will compare conventional physiotherapy and conventional physiotherapy + fESWT to see if fESWT provides benefits in addition to conventional physiotherapy. Participants: They will receive the conventional physiotherapy program 2 days per week. In addition, the intervention group will receive low-intensity fESWT 1 day per week. Participants' muscle strength, postural balance, range of motion, pain scores and functional status will be assessed.

This description comes directly from the study's public registry record.

Talk to the study team

Berivan Beril Kılıç, Asst. Prof.  ·  +905069496158  ·  berilk@biruni.edu.tr

Always discuss trial participation with your own doctor first.

Locations (1)

Istanbul Faculy of Medicine-Department of Sports MedicineIstanbul, Turkey (Türkiye)Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06688344